The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.
Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Hosted on MSN1h
Here’s Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage UniverseValuation discrepancies in the biotech sector highlight Shuttle Pharma’s incredible potential. With several peer companies in ...
New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
News Medical on MSN1h
New dual-target therapy offers hope for better breast cancer treatmentResearchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at the Peter Doherty Institute of Infection and Immunity (Doherty Institute), in ...
Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.
A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback